BioSpace News Archive

CRISPR Therapeutics today announced it proposes to elect Christian Rommel, Ph.D., to its Board of Directors at the Company’s annual general meeting to be held this year.

Journey Medical Corporation today announced that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California.

Nexalin Technology, Inc. today announced it was selected and provided a poster presentation at the “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment” on March 12, 2024, which was held at the Walter E. Washington Convention Center in Washington, D.C.

PAVmed Inc. today announced that it will host a business update conference call and webcast on Wednesday, March 27, 2024, at 8:30 AM ET.

Zephyr AI, Inc. today announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Co.

Sunbird Bio will be presented at the upcoming Tau2024 Global Conference taking place March 25-26, 2024 in Washington, D.C.

Allurion Technologies, Inc. today announced that it will be participating in the 34th Annual Oppenheimer Healthcare MedTech & Services Conference, taking place on March 12 - 13, 2024.

Simulations Plus, Inc. today announced that Shawn O’Connor, chief executive officer, will be hosting a fireside chat at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024, at 4:30 p.m. Eastern Time.

SK Life Science, Inc. announced an update on the use of cenobamate, an anti-seizure medication sold as XCOPRI® CV in the U.S. Data were published in Epilepsia last week providing an update on the real-world experience of the more than 100,000 unique patient exposures recently confirmed across the U.S. and the rest of the markets where cenobamate is available.

The Board of National Cancer Center is pleased to announce that Michelle Stack has joined as CEO. Ms. Stack replaces long-time leader Regina English, who is now Executive Director Emerita and Board member-at-large.